Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression

BACKGROUND: Medulloblastoma (MB) is the most common pediatric brain tumor. Although standard-of-care treatment generally results in good prognosis, many patients exhibit treatment-associated lifelong disabilities. This outcome could be improved by employing therapies targeting the molecular drivers...

Descripción completa

Detalles Bibliográficos
Autores principales: Wynn, Daniel T, Rodriguez-Blanco, Jezabel, Long, Jun, Yang, Fan, Shen, Chen, Fei, Dennis, Tang, Hsin-Yao, Hanson, Derek, Robbins, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586216/
https://www.ncbi.nlm.nih.gov/pubmed/36299796
http://dx.doi.org/10.1093/noajnl/vdac144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586216/
https://www.ncbi.nlm.nih.gov/pubmed/36299796
http://dx.doi.org/10.1093/noajnl/vdac144

Ejemplares similares